Lower levels of PSA-NCAM have been reported in the entorhinal cortex of patients with Alzheimer’s Disease and Parkinson’s Disease and correlate inversely with hyperphosphorylated tau accumulation [36]. The gene discussed is MAPT; the disease is Alzheimer disease.